(Q37899201)

English

Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?

scientific article published on 15 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

author name string

László Selmeci

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

15 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Free Radical Research

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1115-1123

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Microtiter plate assay for phagocyte-derived taurine-chloramines

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Biochemical and spectrophotometric significance of advanced oxidized protein products

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Increased level of advanced oxidation protein products in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Evaluation of oxidative stress in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Involvement of oxidative stress in the relapse of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Modification of the oxidative stress biomarker AOPP assay: application in uremic samples

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Oxidative stress: from basic research to clinical application

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Biochemistry and pathology of radical-mediated protein oxidation

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Non-enzymatic covalent modifications of proteins: mechanisms, physiological consequences and clinical applications

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The oxidative environment and protein damage.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Albumin--an important extracellular antioxidant?

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The antioxidants of human extracellular fluids

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The antioxidant properties of serum albumin

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The importance of proteins in defense against oxidation.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Albumin is the major plasma protein target of oxidant stress in uremia

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Oxidation of albumin is enhanced in the presence of uremic toxins

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Investigation of albumin properties in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Glycoxidation and inflammation in chronic haemodialysis patients

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Importance of oxidatively modified proteins in chronic renal failure

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Respective role of uraemic toxins and myeloperoxidase in the uraemic state

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Quantification and significance of protein oxidation in biological samples

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Functional consequences of tryptophan modification in human fibrinogen

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Fibrinogen is a co-antioxidant that supplements the vitamin E analog trolox in a model system

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Fibrinogen is an antioxidant that protects beta-lipoproteins at physiological concentrations in a cell free system

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Fibrinogen and fibrin.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Coagulation in vertebrates with a focus on evolution and inflammation

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Convergent evolution of apolipoprotein(a) in primates and hedgehog

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Mapping of a minimal apolipoprotein(a) interaction motif conserved in fibrin(ogen) beta - and gamma -chains

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Protein damage in diabetes and uremia--identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Oxidative stress and inflammation in pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Advanced Glycation End Products and Advanced Oxidation Protein Products in Hemodialyzed Patients

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Total Hydroperoxide and Advanced Oxidation Protein Products in Preterm Hypoxic Babies

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.602074

21 January 2018

Identifiers

10.3109/10715762.2011.602074

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37899201&oldid=2128052610"